Literature DB >> 32317345

Covid-19 and mental health: a transformational opportunity to apply an evidence-based approach to clinical practice and research.

Katharine Smith1,2, Edoardo Ostinelli1,2, Andrea Cipriani3,2.   

Abstract

Entities:  

Keywords:  adult psychiatry; depression & mood disorders; schizophrenia & psychotic disorders; suicide & self-harm

Mesh：

Substances：

Year:  2020        PMID： 32317345     DOI： 10.1136/ebmental-2020-300155

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN： 1362-0347


× No keyword cloud information.
  10 in total

1.  Post-traumatic stress disorder and psychological distress in Chinese youths following the COVID-19 emergency.

Authors:  Leilei Liang; Tingting Gao; Hui Ren; Ruilin Cao; Zeying Qin; Yueyang Hu; Chuanen Li; Songli Mei
Journal:  J Health Psychol       Date:  2020-07-06

2.  COVID-19, mental health and ethnic minorities.

Authors:  Katharine Smith; Kamaldeep Bhui; Andrea Cipriani
Journal:  Evid Based Ment Health       Date:  2020-07-17

Review 3.  Suicide Risk Assessment Using Machine Learning and Social Networks: a Scoping Review.

Authors:  Gema Castillo-Sánchez; Gonçalo Marques; Enrique Dorronzoro; Octavio Rivera-Romero; Manuel Franco-Martín; Isabel De la Torre-Díez
Journal:  J Med Syst       Date:  2020-11-09       Impact factor: 4.460

4.  No adverse events were observed in clozapine-treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan.

Authors:  Masahiro Hata; Michiko Fujimoto; Koji Kanai; Kenji Yoshiyama; Yoshitaka Nakatani; Daiji Nakabayashi; Saki Maemura; Shinya Kawata; Takaaki Hakozaki; Shuya Nishikura; Aiko Umemoto; Toru Sasada; Kazuhiko Iwata; Hideki Tanaka; Akiko Mamoto; Yuuki Toi; Norio Taniguchi; Makiko Saito; Yoshio Kimura; Kazuko Kishimoto; Megumi Hayami; Manabu Ikeda
Journal:  Neuropsychopharmacol Rep       Date:  2021-02-19

5.  Psychotropics and COVID-19: An analysis of safety and prophylaxis.

Authors:  H Javelot; C Straczek; G Meyer; C Gitahy Falcao Faria; L Weiner; D Drapier; E Fakra; P Fossati; S Weibel; S Dizet; B Langrée; M Masson; R Gaillard; M Leboyer; P M Llorca; C Hingray; E Haffen; A Yrondi
Journal:  Encephale       Date:  2021-09-02       Impact factor: 1.291

6.  The disquietude of clozapine continuation during the COVID-19 pandemic.

Authors:  Sheikh Shoib; Vidya Bharati-Sinha; Sana Javed; Ahmet Gürcan; Gamze Gürcan; Soumitra Das; Miyuru Chandradasa; Fahimeh Saeed
Journal:  Health Sci Rep       Date:  2022-02-07

Review 7.  COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services.

Authors:  Edoardo G Ostinelli; Katharine Smith; Caroline Zangani; Michael J Ostacher; Anne R Lingford-Hughes; James S W Hong; Orla Macdonald; Andrea Cipriani
Journal:  BMC Psychiatry       Date:  2022-03-31       Impact factor: 3.630

8.  Mental Health and the SARS-COV-2 Epidemic-Polish Research Study.

Authors:  Monika Talarowska; Jan Chodkiewicz; Natalia Nawrocka; Joanna Miniszewska; Przemysław Biliński
Journal:  Int J Environ Res Public Health       Date:  2020-09-25       Impact factor: 3.390

Review 9.  Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.

Authors:  Alessandro Orsini; Martina Corsi; Andrea Santangelo; Antonella Riva; Diego Peroni; Thomas Foiadelli; Salvatore Savasta; Pasquale Striano
Journal:  Neurol Sci       Date:  2020-08-06       Impact factor: 3.307

10.  Comparison of Prevalence and Risk Factors of PTSS Between Chinese Patients With Depression and Non-depressed Controls During COVID-19 Outbreak.

Authors:  Min Peng; Xinran Song; Luyu Liu; Weifeng Zhao; Pingmei Lai; Guanglin Bao; Tianyou Guo; Xiangyang Zhang
Journal:  Front Psychiatry       Date:  2022-01-03       Impact factor: 4.157
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.